NPTX2 and prostate cancer: Additionally, the detailed clinical parameters of the enrolled patients are shown in TCGA database, which demonstrated that the expression of NPTX2 in prostate cancer was significantly lower than that in control tissues (p < 0.05, Figure 1A).